drugset / Trial / NCT00029315

Intraventricular Rt-PA in Patients With Intraventricular Hemorrhage

NCT00029315

Phase 2 Completed 30 enrolled Johns Hopkins University
RandomizedDouble-blindTreatment

Summary

This is a study to evaluate how recombinant tissue plasminogen activator (rt-PA) is utilized in patients with intraventricular hemorrhage (IVH). rt-PA is a drug that has been shown to dissolve blood, and may allow intraventricular catheters to be more effective for a longer period of time.

Timeline

Start
2001-09
Primary completion
Completion
2004-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Alteplase Protein / enzyme biologic Intravenous

Indications